3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Advanced Colorectal Cancer
1
Interventions
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Cisplatin
1
Cerebral Decortication
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
defactinib
×
30 days
×
Clear all
No trials found.